Aims The activation of endothelial Ca 2+ -dependent K + -channels, K Ca 3.1 (IK Ca ), and K Ca 2.3 (SK Ca ) has been proposed to be a prerequisite for endothelial hyperpolarization, which subsequently hyperpolarizes and relaxes smooth muscle [endothelium-derived hyperpolarizing factor (EDHF)-type dilation] and initiates conducted dilations. Although EDHF is the main mediator of acetylcholine (ACh)-induced dilation in the murine skeletal microcirculation, the differential contribution of K Ca 3.1 and K Ca 2.3 is not known.
Introduction
The endothelium acts as a key player in the control of tissue perfusion and peripheral resistance by releasing vasoactive factors which modulate vascular smooth muscle tone. In addition to the classical autacoids nitric oxide (NO) and prostaglandins, an endothelium-derived hyperpolarizing factor (EDHF) contributes to the decisive endothelial control of vascular diameter. Autacoids are released in response to stimulation with agonist such as acetylcholine (ACh) or bradykinin but also upon changes of haemodynamic forces, e.g. pressure leading to vessel distension or blood flow. The chemical nature of EDHF is still a matter of controversy and candidate molecules accounting for EDHF activity include among others products of cytochrome-P450 epoxygenases, K + ions, or hydrogen peroxide (for review see 1, 2 ). Recently, it was proposed that a chemical entity may not be needed for EDHF-signalling. [3] [4] [5] Indeed, evidence has accumulated that smooth muscle hyperpolarization and dilation may be achieved by direct current transfer from endothelial to smooth muscle cells through myoendothelial gap junctions. 6, 7 Regardless of EDHFs nature, the EDHF-dilator response is of special interest in resistance-sized vessels in the microcirculation 8 because blockade of NO and prostaglandins attenuated agonist-induced dilations only to a small extent [9] [10] [11] and were likewise intact in animals in which the NO/cGMP/cGMP-dependent kinase pathway is disrupted. Despite the unresolved identity of EDHF, it is widely accepted that an endothelial hyperpolarization is the initial step to elicit the EDHF-type response which was concluded from experiments on isolated small arteries. Endothelial hyperpolarization is mediated by the activation of calcium-dependent K-channels (K Ca ), [14] [15] [16] and from studies examining channel expression and functional responses in the presence of pharmacological blockade it was suggested that the intermediate-(IK Ca , encoded by the K Ca 3.1 gene) and the small-conductance K Ca (SK Ca , encoded by K Ca 2.3) mediate endothelial hyperpolarization in response to Ca 2+ -mobilizing stimuli. [17] [18] [19] [20] [21] Intriguingly, in animals deficient for K Ca 3.1 the ACh-induced dilation was severely attenuated in the microcirculation 22 implicating an important role for K Ca also in arterioles.
Endothelial hyperpolarization not only elicits an EDHF-type dilation but also serves to coordinate cellular behaviour along the vessel length. Endothelial cells are tightly coupled by gap junctions that allow the spread of locally initiated hyperpolarization to remote sites giving rise to conducted dilations which reflect the coordination of vascular function. 23, 24 Herein, K Ca channels have been proposed to initiate a conducting response, 25, 26 although it is currently unclear which channels are involved and what their precise roles are. In addition, conducted dilations cover larger distances than can be expected from pure electrotonic conduction, 24 which implies an amplification mechanism that regenerates the travelling signal. Very recently, a Ca 2+ wave spreading along the endothelium has been suggested to contribute to conducting dilations, 26, 27 which could activate endothelial K Ca -channels at distant sites and thereby refresh the hyperpolarization. However, in isolated arterioles endothelial Ca 2+ increased only locally, 28 which is consistent with the view that activation of K Ca 3.1 and/or K Ca 2.3 initiates the response. Therefore, the contribution of K Ca channels in the conduction process is even less well defined.
In the present study, we assessed the role of K Ca 3.1 and K Ca 2.3 in agonist-induced endothelial hyperpolarizations and dilations in the microcirculation. Moreover, we aimed to elucidate specifically the role of K Ca 3.1 in the initiation and transmission of conducted dilations. This was achieved by studying vascular responses in the microcirculation in vivo in mice carrying a targeted disruption of the K Ca 3.1 gene. We have previously shown that these animals exhibit an attenuated EDHF-type dilator response and mild arterial hypertension. 22 
Methods

Experimental setup
The investigation conformed with the guide for the care and use of laboratory animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by local authorities (Ministerium für Landwirtschaft und Umwelt des Landes Schleswig-Holstein, V312-72241.122-2). Experiments were performed in mice deficient for the K Ca 3.1 channel (K Ca 3.12/2) and wild-type littermates with a mixed genetic background (SV129, C57BL6). 22 Animals at the age of 3-6 months were anaesthetized (medetomidin, fentanyl, midazolam) and the cremaster muscle was prepared for intravital microscopy as described. 11 Microscopic images were displayed on a monitor at 700-fold magnification, recorded and later digitized for measurement of luminal diameters. The resolution after digitization was about 1 mm. All animals were killed at the end of the experiment by pentobarbital.
Membrane potential recordings
Measurements were performed as previously described. 29 In brief, arterioles in the cremaster with a diameter between 30 and 60 mm were carefully dissected free from the surrounding tissue over a short distance. A glass microelectrode (80-120 MV, filled with 3 mol/L KCl containing 5% carboxyfluorescein in the tip) connected to a membrane potential amplifier (SEC 1L, NPI Advanced Electronics, Tamm, Germany) was positioned vertical to the vessel axis and advanced using an electronic micromanipulator equipped with a piezo stepper. Successful impalement was verified by a sharp deflection of the potential recording, a low resistance over the cell membrane, and a stable potential for at least 30 s. The cell type being impaled was analysed following each recording by the pattern of labelling with carboxyfluorescein, which enabled the identification of the cell by its orientation relative to the vessel axis. Data were collected at a sampling rate of 500 Hz.
Experimental protocols 2.3.1 Diameter changes upon agonist stimulation
The cremaster was continuously superfused with the cyclooxygenase inhibitor indomethacin (3 mmol/L) and the NO-synthase inhibitor N-nitro-L-arginine (L-NA, 30 mmol/L) throughout the experiment unless otherwise stated. Arteriolar diameters were measured shortly before and during the local superfusion of ACh (0.1-10 mmol/L), adenosine (Ado, 0.3-10 mmol/L), sodium-nitroprusside (SNP, 0.1-10 mmol/L), or an opener of K Ca -channels (5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazole-2-one, DCEBIO, 10 mmol/L, solved in 0.5% DMSO). Increasing concentrations were applied consecutively with a recovery period of 5 min. Some of the agonists were restudied after application of UCL1684 (1 mmol/L), a specific inhibitor of K ca 2.3-channels. 30 The maximal diameter of the arterioles was obtained during superfusion of a combination of different vasodilators (Ado, SNP, ACh, each 30 mmol/L) at the end of the experimental protocol.
Conducted dilations and membrane potential
All preparations were treated with indomethacin and L-NA. In each animal, one or two second-order arterioles located in the central region of the tissue were studied. Conducted vasomotor responses were initiated as described 31 by locally confined stimulation with ACh (10 mmol/L) or DCEBIO (1 mmol/L) that were delivered through glass micropipettes (tip opening 1-2 mm) positioned in close proximity of the arterioles by a short pressure pulse (140 kPa, 100-300 ms). If a response was obtained at the application site (local), the same stimulus was applied again and remote upstream sites were recorded at distances of 550 and 1100 mm. For membrane potential measurements the arterioles were similarly stimulated after successful impalement and recording of the resting membrane potential by ACh application via a micropipette. However, the periods of pressure ejection were varied (from 100 to 1000 ms) to achieve increasing local concentrations. Before application of the next pressure pulse, the membrane potential was allowed to return to baseline level. Maximal diameters of the vessels under study were determined as described earlier.
Statistics and calculations
Vascular tone is expressed as the quotient of resting and maximal diameter and is dimensionless. Diameter changes were normalized to the maximal possible response:
where D Tr is the diameter after treatment, D Co the control diameter before treatment, and D Max the maximal possible diameter that is the maximally dilated diameter for dilations or the minimal luminal diameter (zero) for constrictions. The temporal characteristic of the responses was considered by calculation of the interval between stimulus application and attainment of peak diameter (time to peak) and of the response duration (interval from stimulation to recovery). Comparisons within groups were performed using paired t-tests, and, for multiple comparisons, probability values were corrected according to Bonferroni. Data between groups were compared with ANOVA followed by post hoc analysis of the means. Differences were considered significant at a corrected error probability of P , 0.05. Data are presented as mean+SEM.
Results
Arteriolar resting tone
A total of 266 arterioles with a maximal diameter of 36 + 1 mm were studied in 31 mice. 
Agonist-induced dilations
Acetylcholine induced a concentration-dependent dilation in wt animals, which was significantly reduced in K Ca 3.12/2 animals. At low and intermediate ACh concentrations (0.1-1 mmol/L) dilations were almost abolished in K Ca 3.12/2 mice while at higher concentrations (3-10 mmol/L, Figure 1A ) the dilation was partially intact. This remaining dilation in K Ca 3.12/2 animals was abolished after blockade of K Ca 2.3 by UCL1684 (1 mmol/L). In contrast, UCL1684 did not attenuate ACh-induced dilations in wt mice ( Figure 1A ) but reduced unstimulated diameters in these mice (from 11 + 1 to 7+ 1 mm, P , 0.001). Resting diameters remained unaffected by UCL1684 in K Ca 3.12/2 animals (data not shown). In contrast to ACh, dilations induced by the NO-donor SNP were not attenuated in K Ca 3.12/2. After additional application of UCL1684 the responses also remained intact in these mice although we observed a small attenuation at the highest concentration of SNP ( Figure 1B) . This demonstrates that the abrogation of the ACh-dilation is not due to an incapability of K Ca 3.12/2 vessels to relax. Likewise, dilations in response to adenosine remained fully intact in K Ca 3.12/2 animals ( Figure 1C ) which suggests that adenosine-dilations do not depend on this channel. DCEBIO at the concentration of 10 mmol/L induced a significant dilation amounting to 40% in wt animals which was not due to the solvent used (0.5% DMSO) and completely absent in K Ca 3.12/2 mice ( Figure 1D ).
Conducted dilations
Brief local application of ACh onto the arterioles (ejected at a high concentration from a micropipette) evoked a transient dilation in wt mice at the stimulation site (local) that attained a maximum of 64 + 5% within 8 + 1 s (time to peak) and lasted for 27 + 4 s (response duration). In K Ca 3.12/2 mice, ACh induced likewise a dilation at the stimulation site. The dilation was delayed in K Ca 3.12/2 mice which is reflected by a prolonged time to peak (14 + 2 s, P , 0.05) and an extended response duration (41 + 5 s, P , 0.01). The delay of the dilation was also reflected by a significant attenuation of the dilation at early time points (at 8 s: 38 + 7 vs. 58 + 7% in wt, P , 0.05). However, the maximum dilation that was achieved during the response was not significantly different from wt and only tended to be smaller in K Ca 3.12/2 mice (53 + 5%, P ¼ 0.18). In both genotypes, the local dilation was conducted with a high velocity to distant upstream sites ( Figure 2 ) and the arterioles started to dilate at a distance of 1100 mm without measurable time delay (,1 s). In wt, the amplitude of the dilation and the response duration was not reduced even at the furthest distance studied (Figure 3) . In contrast, the amplitude of the dilation was significantly reduced in K Ca 3.12/2 mice ( Figure 3 ) without an alteration of the time-dependent behaviour of the response when compared with the local dilation ( Figure 2) . In a second group of experiments, arterioles in K Ca 3.12/2 mice were stimulated to elicit a local dilation of a shortened duration and lower amplitude. The amplitude of the dilations at distant sites decreased likewise under these conditions (Figure 3) .
In a different experimental series, the effect of a blockade of K Ca 2.3 channels by UCL1684 was studied. In contrast to the lack of K Ca 3.1, the blockade of K Ca 2.3 channels in wt mice did neither attenuate the maximal amplitude of the dilation at the local (Con: 61 + 11, UCL1684: 59 + 6%) nor at remote, distant sites (550 mm: 59 + 8 vs. 48 + 5%; 1100 mm: 54 + 13 vs. 53 + 8%, Con vs. UCL1684, respectively). The time-dependent behaviour of the dilation was likewise unaffected by UCL1684 (Figure 4) . In contrast, UCL1684 completely abrogated local and conducted dilations in K Ca 3.12/2 mice (Figure 3) . Finally, K Ca 3.1 channels were stimulated by local application of DCEBIO through micropipettes. DCEBIO elicited a local dilation in wt which was of a smaller maximal amplitude (47 + 5%) when compared with ACh. Nevertheless, the dilation conducted to remote sites ( Figure 5 ), but the maximal amplitude decreased with distance (550 mm: 39 + 5%, 1100 mm: 20 + 7%, P , 0.05 vs. local site). In K Ca 3.12/2 mice, local stimulation with DCEBIO did not initiate a dilation at the local or remote sites ( Figure 5) . Application of the solvent of DCEBIO did not induce diameter changes in wt or K Ca 3.12/2 animals (data not shown).
Membrane potential changes in EC
Membrane potentials in endothelial cells were measured in small arterioles of a similar size in wt and K Ca 3.12/2 (maximal diameter of 38 + 2 and 40 + 5 mm, respectively) as described previously. 29 The resting membrane potential amounted to 232 + 3 mV in wt (10 arterioles in 4 mice) which was not significantly different from K Ca 3.12/2 mice (231 + 4 mV, 8 arterioles in 3 animals). Local application of ACh from a micropipette induced a rapid Figure 2 Time course of local and conducted responses upon acetylcholine stimulation. Local, brief application of ACh (1 mmol/L) induced a transient dilation at the stimulation site (A) that was conducted to upstream remote sites (B: 550 mm and C: 1100 mm) without measurable delay and a similar amplitude in wild-type (n ¼ 9). In K Ca 3.12/2 animals (n ¼ 7) the local dilation tended to be attenuated but the duration was longer. Nevertheless the response was conducted to upstream sites. In contrast to wt animals, the amplitude of the conducted dilation decreased with distance. Dilation is expressed as % of maximal response, vertical dashed line denotes ACh application. n, number of arterioles measured in eight and seven animals.
hyperpolarization with a maximal amplitude of 214 + 2 mV (stimulation time of 0.5 s) in wt arterioles ( Figure 6 ). Prolonging the pulse application of ACh (and thereby increasing the local concentration) enhanced the duration of the hyperpolarization without significantly affecting the amplitude ( Figure 6) . Interestingly, the hyperpolarization in response to ACh was reduced in K Ca 3.12/2 arterioles at all stimulation intervals by 75% (Figure 6) . Thus, the maximal amplitude of the hyperpolarization at a stimulation period of 0.5 s amounted to 23 + 1 mV (P , 0.01 vs. wt). Similar to wt, the duration of the hyperpolarization was prolonged with longer periods of ACh stimulation, but the amplitude did not increase significantly ( Figure 6 ).
Discussion
The present data demonstrate a critical role of K Ca 3.1 (IK Ca ) in endothelial hyperpolarization and dilation upon ACh stimulation in skeletal muscle arterioles in vivo. Moreover, the dilatory activity of the channel is contributing to the control of resting diameter and its pharmacological activation by DCEBIO initiates dilation in wild-type animals which was not seen in K Ca 3.12/2 mice. In contrast to K Ca 3.1, the K Ca 2.3 (SK Ca ) channel is less important in the dilator response to ACh, because blockade of K Ca 2.3 by UCL1684 did not reduce the response in wild-type animals and exhibited an attenuating effect only in mice lacking K Ca 3.1. Most interestingly, pharmacological activation of K Ca 3.1 initiates a conducted dilatory response and our data suggest that the channel may contribute to the amplification of the signal which travels along the vascular wall because the amplitude of the dilation decreased with distance in mice lacking K Ca 3.1 but not wild-type animals. Such a role does apparently not apply to the K Ca 2.3 channel because its blockade was without effect.
In response to agonist stimulation, endothelial hyperpolarization is considered to be a crucial step for the initiation of EDHF-type dilation 1,2 and was suggested to be mediated by opening of K Ca -channels as deduced from experiments performed on isolated small and large arteries. 15, 21 The endothelial K + -channels mediating the initial hyperpolarization have been identified as K Ca 3.1 and K Ca 2.3 in different species using electrophysiological, immunohistochemical, Figure 3 Maximal amplitude and duration of conducted ACh dilations. The maximal amplitude and duration of the ACh dilation is depicted over distance from the stimulation site. In wt (white bars), the amplitude of dilations at remote sites was not significantly different from the local site. In contrast, a significant reduction of the amplitude was found in K Ca 3.12/2 animals independent of the height of the local amplitude initiated by ACh stimulation (high amplitude: gray; low amplitude: hatched bars). The duration of the response was prolonged in K Ca 3.12/2 at the local site if a high amplitude was initiated but decreased with distance. The K Ca 2.3 channel blocker UCL1684 (1 mmol/L, black bars) abrogated dilations in K Ca 3.12/2 mice. In cases without an identifiable maximum (e.g. after UCL), diameter was averaged for 15 s after stimulation and taken instead. *P , 0.05, **P , 0.01 vs. local site, #P , 0.01 vs. wt. and molecular biology approaches. [16] [17] [18] [19] 32 Furthermore, using a more definite gene-targeting approach, i.e. generation of K Ca 3.1-deficient mice, we recently demonstrated that K Ca 3.1 and K Ca 2.3 contribute to a similar degree to endothelial K + -currents and the ensuing dilation in large conducting vessels. 22 However, in microcirculatory vessels the differential contribution of K Ca 3.1 and K Ca 2.3 has not been well characterized because in most studies a combination of blockers was used which prevents further differentiation. Moreover, abrogation of the endothelial hyperpolarization by K Ca blockers has not been verified precluding exact identification of the targeted cell type. The present study confirms the significant impact of K Ca 3.1 in ACh-induced EDHF-mediated dilations (in the absence of NO and prostaglandins) and further demonstrates that K Ca 2.3 mediates the remaining dilation which is observed in K Ca 3.1-deficient animals only at high concentrations of ACh. Moreover, the sole blockade of K Ca 2.3 by the specific blocker UCL1684 30 did not affect ACh responses in wild-type animals suggesting that K Ca 2.3, unlike K Ca 3.1, is not of major importance for the dilator response. This observation is in line with previous observations using a different blocker of this channel (apamin). 29 Intriguingly, UCL1684 only exhibited an attenuating effect in animals deficient for K Ca 3.1 indicating a role for K Ca 2.3 only in these mice. However, K Ca 2.3 is apparently unable to compensate for the lack of K Ca 3.1. In contrast to the striking differences in ACh and DCEBIO responses, dilations to adenosine, which have been suggested to depend on the release of endothelial autacoids, 33 were completely unaffected by K Ca 3.1 deficiency in the absence of NO and prostaglandins. Therefore we conclude that these agonists (ACh vs. adenosine) elicit dilations in the murine microcirculation by distinct mechanisms, one involving endothelial K Ca 3.1 the other not.
Another major finding of the present study is that the resting tone of K Ca 3.1-deficient arterioles was enhanced compared with wild-type vessels with intact NO and prostaglandin synthesis as well as after their blockade. The enhanced arteriolar tone in K Ca 3.1-deficient mice suggests that endothelial K Ca 3.1 channels exert a tonic dilator influence on smooth muscle and that K Ca 3.1-deficiency may affect total peripheral vascular resistance and arterial pressure. Indeed, telemetric measurements revealed a significant increase in arterial pressure in K Ca 3.1-deficient animals. 22 The importance of K Ca 3.1 in cremaster arterioles is further supported by our finding that the pharmacological opening of this channel by the fairly selective DCEBIO elicited a robust dilation. This dilation seems to be due to activation of K Ca 3.1 alone because it was absent in K Ca 3.1-deficient mice although DCEBIO has been reported to also activate K Ca 2.3, albeit with a 10-fold lower potency. 34 In any case, the data clearly demonstrate the contribution of K Ca 3.1 channels to the control of resting vascular tone or diameters following activation, suggesting that this channel provides an important mechanism of endothelial control to arteriolar diameter.
Additional mechanistic insight into the role of K Ca 3.1 channels was obtained by the measurement of endothelial membrane potential in these arterioles. Endothelial hyperpolarization to ACh was strongly attenuated in K Ca 3.1-deficient mice (by about 75%). Thus, this demonstrates for the first time that K Ca 3.1 channels are indeed crucial to support an endothelial hyperpolarization in response to ACh in these arterioles. Nonetheless, this strong impairment of hyperpolarization was rather surprising since K Ca 2.3 channels are present and we have previously shown that the endothelial hyperpolarization was likewise attenuated by apamin, 29 which selectively blocks K Ca 2.3 channels. Although this is at first glance conflicting, both K Ca -channels may be required to elicit a full endothelial response. Interestingly, neither apamin 29 nor UCL1684 (this study) exhibited a striking attenuating effect on the mechanical response. Conversely, high concentrations of ACh induced a marked dilation in K Ca 3.1-deficient arterioles despite the strong attenuation of the endothelial hyperpolarization. This suggests that small remaining endothelial hyperpolarizations are sufficient to elicit a pronounced dilator response.
Endothelial hyperpolarization is not only important to elicit EDHF-type dilation but also critically contributes to the coordination of vascular responses. This coordination is Figure 5 Pharmacological opening of K Ca 3.1 elicited a conducted dilation. Local, brief application of the K Ca 3.1-opener DCEBIO (1 mmol/L) induced a rapid, transient dilation at the stimulation site (A) in wild-type (n ¼ 9) that was conducted to upstream sites (B: 550 mm and C: 1100 mm) without delay. In contrast to ACh, the amplitude and duration of the dilation decreased with increasing distances. In K Ca 3.12/2 animals (n ¼ 7), local application of DCEBIO did not initiate significant diameter changes at local or upstream sites. Dilation is expressed as % of maximal response, vertical dashed line denotes DCEBIO application. n, number of animals.
reflected by the conduction of locally initiated dilations 24 and relies most likely on the endothelium which allows the spread of locally initiated responses in a gap junctiondependent manner. 23, 31 Such conducted responses can be initiated by the activation of K Ca 3.1 channels because DCEBIO elicited these responses only in wild-type but not in K Ca 3.1-deficient mice. Interestingly, the amplitude of the dilation diminished with distance in case of DCEBIO, but not when conducted responses were initiated by ACh. This suggests that ACh, in contrast to DCEBIO, exerts a distinct action which allows the amplification of the signal while travelling. Recently, it was suggested that in addition to hyperpolarization intracellular increases of Ca 2+ propagate along the vessel wall (termed Ca 2+ wave) and may contribute to the conduction process. 26, 27 If this is the case, it may be speculated that such a Ca 2+ wave activates endothelial K Ca -channels which in turn amplify the conducting hyperpolarization. The present data are in line with this hypothesis and suggest a possible contribution of K Ca 3.1 in the regeneration of the conducting hyperpolarization signal since the amplitude of the dilation decreases with distance only in K Ca 3.1-deficient mice. In contrast, blockade of K Ca 2.3 using UCL1684 did not alter conducted dilations suggesting that this channel plays only a minor role herein. Together with the finding after global ACh stimulation the differential contribution of the channels to conducted responses further underpins their distinct roles in the microcirculation. However, the endothelial hyperpolarization at the application site of ACh was already strongly reduced in K Ca 3.1-deficient mice which may have altered the propagation process and possible amplification mechanisms per se.
In summary, the endothelial K Ca 3.1 channel significantly contributes to the control of vascular diameter in the microcirculation at rest and during endothelial stimulation. This is achieved by mediating a strong endothelial hyperpolarization in response to ACh. In contrast to ACh, adenosine initiates distinct pathways which are independent of K Ca 3.1. Moreover, K Ca 3.1-mediated hyperpolarization is capable of initiating conducted responses and K Ca 3.1 possibly contributes to the conduction process itself through an amplification of the travelling signal. The role of the second important endothelial K Ca -channel in arterioles remains obscure but K Ca 2.3 seems to contribute to agonist-induced dilations in the absence of K Ca 3.1. Future experiments will have to illuminate its role and possibly provide mechanistic insight into distinct functions of these channels. In keeping with a predominant role of K Ca 3.1 in EDHF-type dilation and conducted responses, endothelial K Ca channels provide an attractive target to pharmacologically manipulate diameter in resistance-sized arterioles and selective openers of K Ca 3.1 channels (NS308, DCEBIO) 35 represent promising candidate molecules for the treatment of hypertension. Figure 6 Membrane potential changes in endothelial cells in response to acetylcholine. Endothelial membrane potentials (MP) were measured using sharp electrodes inserted into arterioles in vivo. The electrode was filled with dye (carboxyfluorescein) which diffused during measurement into the cell and allowed identification of the cell type (inset in B shows endothelial cell, dashed lines: vessel wall). Brief local stimulation with ACh (vertical dashed line) using a micropipette induced significant hyperpolarization in wt arterioles (open symbols). Note that longer stimulation periods (from 0.1 to 1.0 s, increasing the local effective concentration, A-D) did not change the amplitude of the hyperpolarization but prolonged the duration. In K Ca 3.12/2 vessels (filled symbols), the amplitude of the hyperpolarization was strongly attenuated and shortened. Longer stimulation periods did not further enhance the amplitude. Data were obtained in 10 arterioles in 4 (wt) or 8 arterioles in 3 mice (K Ca 3.12/2).
